Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155947 | SCV000205659 | uncertain significance | not specified | 2013-07-31 | criteria provided, single submitter | clinical testing | The Cys24603Arg variant in TTN has not been reported in individuals with cardiom yopathy or in large population studies. Computational analyses (biochemical ami no acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. Additional information is needed to fully assess the clinical significance of the Cys24603Arg variant. |
Labcorp Genetics |
RCV000474180 | SCV000542811 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-01-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002484942 | SCV002794270 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003137674 | SCV003827389 | uncertain significance | not provided | 2021-09-11 | criteria provided, single submitter | clinical testing |